Generics
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
44
NCT01182246
AXP107-11 in Combination With Standard Gemcitabine (Gemzar® ) Therapy for Treatment in Patients With Pancreatic Cancer
Phase: Phase 1/2
Role: Lead Sponsor
Start: Nov 30, 2010
Completion: Mar 31, 2016
Loading map...